Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 133 participants.
Also called NCT01994941
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 133 participants
- Sponsor
- Registry
-
NCT01994941
-
- Other papers using this trial's data
- Genotyping-guided approach versus the conventional approach in selection of oral P2Y12 receptor blockers in Chinese patients suffering from acute coronary syndrome
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Hong Kong SAR China
- Registry status
- Completed
Technical summary
Registry record NCT01994941. Randomized; no masking; primary purpose treatment. Start 2013-08 (registry gives no type); primary completion 2015-08 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Genotype Guided Versus Conventional Approach in Selection of Oral P2Y12 Receptor Blocker in Chinese Patients Suffering From Acute Coronary Syndrome
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Ticagrelor
- Lead sponsor
- The University of Hong Kong
Record details
- Record id
cardio:ct-nct01994941- Content hash
182296228eece99224d6dfcf2e6e8810672402fe0f6e70f7e57db4ba8ce43ca0